- Two-Year Outcomes after Transcatheter or Surgical Aortic-Valve Replacement
[作者：Kodali, SK; Williams, MR; Smith, CR; Svensson, LG; Webb, JG; Makkar, RR; Fontana, GP; Dewey, TM; Thourani, VH; Pichard, AD; Fischbein, M; Szeto, WY; Lim, S; Greason, KL; Teirstein, PS; Malaisrie, SC; Douglas, PS; Hahn, RT; Whisenant, B; Zajarias, A; Wang, DL; Akin, JJ; Anderson, WN; Leon, MB,期刊：New England Journal of Medicine, 页码：1686-1695 , 文章类型： Article，,卷期：2012年366-18]
- Background The Placement of Aortic Transcatheter Valves (PARTNER) trial showed that among high-risk patients with aortic stenosis, the 1-year survival rates are similar with transcatheter aortic-valve replacement (TAVR) ...
- Registry of Transcatheter Aortic-Valve Implantation in High-Risk Patients
[作者：Gilard, M; Eltchaninoff, H; Iung, B; Donzeau-Gouge, P; Chevreul, K; Fajadet, J; Leprince, P; Leguerrier, A; Lievre, M; Prat, A; Teiger, E; Lefevre, T; Himbert, D; Tchetche, D; Carrie, D; Albat, B; Cribier, A; Rioufol, G; Sudre, A; Blanchard, D; Collet, F; Dos Santos, P; Meneveau, N; Tirouvanziam, A; Caussin, C; Guyon, P; Boschat, J; Le Breton, H; Collart, F; Houel, R; Delpine, S; Souteyrand, G; Favereau, X; Ohlmann, P; Doisy, V; Grollier, G; Gommeaux, A; Claudel, JP; Bourlon, F; Bertrand, B; Van Belle, E; Laskar, M,期刊：New England Journal of Medicine, 页码：1705-1715 , 文章类型： Article，,卷期：2012年366-18]
- Background Transcatheter aortic-valve implantation (TAVI) is an emerging intervention for the treatment of high-risk patients with severe aortic stenosis and coexisting illnesses. We report the results of a prospective m...
- Ablation with Low-Dose Radioiodine and Thyrotropin Alfa in Thyroid Cancer
[作者：Mallick, U; Harmer, C; Yap, B; Wadsley, J; Clarke, S; Moss, L; Nicol, A; Clark, PM; Farnell, K; McCready, R; Smellie, J; Franklyn, JA; John, R; Nutting, CM; Newbold, K; Lemon, C; Gerrard, G; Abdel-Hamid, A; Hardman, J; Macias, E; Roques, T; Whitaker, S; Vijayan, R; Alvarez, P; Beare, S; Forsyth, S; Kadalayil, L; Hackshaw, A,期刊：New England Journal of Medicine, 页码：1674-1685 , 文章类型： Article，,卷期：2012年366-18]
- Background It is not known whether low-dose radioiodine (1.1 GBq [30 mCi]) is as effective as high-dose radioiodine (3.7 GBq [100 mCi]) for treating patients with differentiated thyroid cancer or whether the effects of r...
- Strategies of Radioiodine Ablation in Patients with Low-Risk Thyroid Cancer
[作者：Schlumberger, M; Catargi, B; Borget, I; Deandreis, D; Zerdoud, S; Bridji, B; Bardet, S; Leenhardt, L; Bastie, D; Schvartz, C; Vera, P; Morel, O; Benisvy, D; Bournaud, C; Bonichon, F; Dejax, C; Toubert, ME; Leboulleux, S; Ricard, M; Benhamou, E,期刊：New England Journal of Medicine, 页码：1663-1673 , 文章类型： Article，,卷期：2012年366-18]
- Background It is not clear whether the administration of radioiodine provides any benefit to patients with low-risk thyroid cancer after a complete surgical resection. The administration of the smallest possible amount o...
- Transcatheter Aortic-Valve Replacement for Inoperable Severe Aortic Stenosis
[作者：Makkar, RR; Fontana, GP; Jilaihawi, H; Kapadia, S; Pichard, AD; Douglas, PS; Thourani, VH; Babaliaros, VC; Webb, JG; Herrmann, HC; Bavaria, JE; Kodali, S; Brown, DL; Bowers, B; Dewey, TM; Svensson, LG; Tuzcu, M; Moses, JW; Williams, MR; Siegel, RJ; Akin, JJ; Anderson, WN; Pocock, S; Smith, CR; Leon, MB,期刊：New England Journal of Medicine, 页码：1696-1704 , 文章类型： Article，,卷期：2012年366-18]
- Background Transcatheter aortic-valve replacement (TAVR) is the recommended therapy for patients with severe aortic stenosis who are not suitable candidates for surgery. The outcomes beyond 1 year in such patients are no...
|